Sagimet Biosciences Inc Series A Common Stock
Price & Volume
Stats
See moreOpen | $6.23 |
Previous Close | $6.21 |
Day Range | $6-$6.23 |
52W Range | $1.73-$11.41 |
Market Cap | $201.9M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.78 |
News
See moreYahoo Finance • last month
Sagimet’s License Partner Ascletis Announced Acceptance of New Drug Application for Denifanstat for the Treatment of Moderate to Severe Acne by China’s National Medical Products Administration
Yahoo Finance • last month
Sagimet Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Sagimet Biosciences GAAP EPS of -$0.40 misses by $0.01
Yahoo Finance • 2 months ago
Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
About
CEO | Mr. David A. Happel |
CFO | Mr. Thierry Chauche |
Address | 155 Bovet Road, San Mateo, CA, United States, 94402 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |
